James B. Davis

Preclinical studies comparing different bispecific antibodies for redirecting T cell cytotoxicity to extracellular antigens on prostate carcinomas.

L. Lum, P. Davol, Ryan C. Grabert, 2005, Anticancer research.

Maintenance of Certification Part 4 Credit and Recruitment for Practice-Based Research

J. Klein, R. Wasserman, E. Gotlieb, 2014, Pediatrics.

Anti-CD3 × Anti-Epidermal Growth Factor Receptor (EGFR) Bispecific Antibody Redirects T-Cell Cytolytic Activity to EGFR-Positive Cancers In vitro and in an Animal Model

L. Lum, P. Davol, M. Sundaram, 2006, Clinical Cancer Research.

Anti-CD 3 Anti-Epidermal Growth Factor Receptor ( EGFR ) Bispecific Antibody Redirects T-Cell Cytolytic Activity to EGFR-Positive Cancers In vitro and in an AnimalModel

Paul Liu, L. Lum, P. Davol, 2005 .